This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
CHANGE IN RATINGSAlexander & Baldwin(ALEX) downgraded at Wells from Market Perform to Underperform, Wells Fargo said. Valuation call, as the stock is up more than 30% over the past week.
TD Ameritrade(AMTD - Get Report) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $15 price target. Retail trading remains soft and consensus expectations could prove optimistic.
Cabot Oil & Gas(COG) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company should benefit from higher natural gas prices down the road.
Cornerstone Therapeutics(CRTX) downgraded to sell at TheStreet Ratings.
Dollar Tree(DLTR) downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. Valuation call, based on a $45 price target.
DSW(DSW) rated new Hold at Canaccord. $62 price target. Company faces near-term earnings risks.
Equinix(EQIX) rated new Buy at Deutsche. $225 price target. Company should benefit from more outsourcing for data centers.
Garmin(GRMN) downgraded to hold at TheStreet Ratings.
Lincare Holdings(LNCR) downgraded at Jefferies to Hold from Buy, Jefferies said. $41.50 price target. Competing bids to Linde's $41.50 offer unlikely.
Lam Research(LRCX) downgraded at CLSA from Buy to Outperform, Credit Agricole said. $44 price target. Company could face higher costs and lower NAND spending.
MasterCard(MA - Get Report) downgraded at UBS to Sell from Neutral, UBS said. $403 price target. Slowing growth and unfavorable risk/reward.
Northern Trust(NTRS) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $53 price target. Estimates also boosted, as the company has stable revenue and can expand margins.
NY Community Bancorp(NYB) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $14 price target. Estimates also cut, given lower expected margins and increased competition.
Boston Beer(SAM) downgraded at UBS to Sell from Neutral, UBS said. $103 price target. Topline trends may slow.
Sirona Dental(SIRO) upgraded at Baird from Neutral to Outperform, Robert Baird said. $53 price target. Company faces tough sales comps and is leveraged to Europe.
State Street(STT - Get Report) downgraded at Goldman to Neutral, Goldman Sachs said. Estimates also cut, given lower sales expectations.
SolarWinds(SWI) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $47 price target. Valuation call, as the stock is up more than 50% year-to-date.